Ameritas Advisory Services’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
Other funds holding MBOT
Ameritas Advisory Services's MBOT Position: Q2 2026 in Review
Ameritas Advisory Services opened a new position in Microbot Medical (MBOT) in Q2 2026: 1,186 shares worth $2.31K. The stake represents ﹤0.01% of the portfolio and ranks #1675 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in MBOT as recently as Q3 2025.
Ameritas Advisory Services first reported a position in MBOT in Q1 2023 and has held it in 4 quarters since. The position peaked at $3.62K in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.
- Ameritas Advisory Services held 1,186 shares of Microbot Medical worth $2.31K as of Q2 2026.
- Microbot Medical was a new Ameritas Advisory Services position in Q2 2026.
- Microbot Medical made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1675 holding.
- Ameritas Advisory Services first reported a position in Microbot Medical in Q1 2023 and has held it in 4 quarters since.
- Ameritas Advisory Services's Microbot Medical position peaked at $3.62K in Q3 2025.
- 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.
Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.